AmpliPhi Biosciences Overview
- Year Founded
-
1989
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Financing Rounds
-
13
- Investments
-
5
AmpliPhi Biosciences General Information
Description
Developer of bacteriophage technology intended to control human diseases. The company is focused on improving human health through the development of novel natural and synthetic bacteriophage-based therapies to treat multidrug-resistant bacterial infections and preventable infectious diseases of the microbiome, enabling healthcare professionals to get novel therapies to cure their patients efficiently.
Contact Information
Website
www.targen.comCorporate Office
- 3579 Valley Centre Drive
- Suite 100
- San Diego, CA 92130
- United States
Corporate Office
- 3579 Valley Centre Drive
- Suite 100
- San Diego, CA 92130
- United States
AmpliPhi Biosciences Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
AmpliPhi Biosciences Comparisons
Industry
Financing
Details
AmpliPhi Biosciences Competitors (7)
One of AmpliPhi Biosciences’s 7 competitors is Inovio Pharmaceuticals, a Corporation company based in Plymouth Meeting, PA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Inovio Pharmaceuticals | Corporation | Plymouth Meeting, PA | ||||
| Spero Therapeutics | Formerly VC-backed | Cambridge, MA | ||||
| VBI Vaccines | Corporation | Cambridge, MA | ||||
| Achaogen | Formerly VC-backed | South San Francisco, CA | ||||
| Aridis Pharmaceuticals | Formerly VC-backed | Los Gatos, CA |
AmpliPhi Biosciences Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
AmpliPhi Biosciences Acquisitions (5)
AmpliPhi Biosciences’s most recent deal was a Reverse Merger with Armata Pharmaceuticals. The deal was made on 10-May-2019.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Armata Pharmaceuticals | 10-May-2019 | Reverse Merger | Drug Discovery | ||
| Novolytics | 08-Jan-2016 | Merger/Acquisition | Biotechnology | ||
| Special Phage Services | 13-Nov-2012 | Merger/Acquisition | Pharmaceuticals | ||
| Biocontrol | 07-Jan-2011 | Merger/Acquisition | Drug Discovery | ||
| RGene Therapeutics | 16-Apr-1996 | Merger/Acquisition | Drug Discovery |
AmpliPhi Biosciences Exits (1)
AmpliPhi Biosciences’s most recent exit was on 10-May-2019 from Armata Pharmaceuticals. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Armata Pharmaceuticals | 10-May-2019 | Completed |
|
AmpliPhi Biosciences FAQs
-
When was AmpliPhi Biosciences founded?
AmpliPhi Biosciences was founded in 1989.
-
Where is AmpliPhi Biosciences headquartered?
AmpliPhi Biosciences is headquartered in San Diego, CA.
-
What industry is AmpliPhi Biosciences in?
AmpliPhi Biosciences’s primary industry is Drug Discovery.
-
Is AmpliPhi Biosciences a private or public company?
AmpliPhi Biosciences is a Private company.
-
What is AmpliPhi Biosciences’s current revenue?
The current revenue for AmpliPhi Biosciences is .
-
How much funding has AmpliPhi Biosciences raised over time?
AmpliPhi Biosciences has raised $53.3M.
-
Who are AmpliPhi Biosciences’s investors?
Activation Capital, Burnbrae Group, E-Synergy, Enterprise Partners Venture Capital, and GeneChem are 5 of 12 investors who have invested in AmpliPhi Biosciences.
-
Who are AmpliPhi Biosciences’s competitors?
Inovio Pharmaceuticals, Spero Therapeutics, VBI Vaccines, Achaogen, and Aridis Pharmaceuticals are some of the 7 competitors of AmpliPhi Biosciences.
-
When was AmpliPhi Biosciences acquired?
AmpliPhi Biosciences was acquired on 10-May-2019.
-
Who acquired AmpliPhi Biosciences?
AmpliPhi Biosciences was acquired by Armata Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process